CGON
Cg Oncology Inc.

468
Mkt Cap
$3.44B
Volume
301,458.00
52W High
$45.56
52W Low
$14.80
PE Ratio
-21.47
CGON Fundamentals
Price
$41.75
Prev Close
$42.60
Open
$43.10
50D MA
$40.06
Beta
1.59
Avg. Volume
997,598.91
EPS (Annual)
-$1.16
P/B
4.85
Rev/Employee
$10,079.65
Loading...
Loading...
News
all
press releases
FY2026 EPS Estimates for CG Oncology Increased by Analyst
CG Oncology, Inc. (NASDAQ:CGON - Free Report) - Equities research analysts at Cantor Fitzgerald raised their FY2026 earnings per share estimates for shares of CG Oncology in a research note issued on...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Rating of "Moderate Buy" by Brokerages
CG Oncology, Inc. (NASDAQ:CGON - Get Free Report) has received an average rating of "Moderate Buy" from the thirteen brokerages that are currently covering the firm, MarketBeat Ratings reports. One...
MarketBeat·13h ago
News Placeholder
CG Oncology (NASDAQ:CGON) Director Sells $41,430.00 in Stock
CG Oncology, Inc. (NASDAQ:CGON - Get Free Report) Director Leonard Post sold 1,000 shares of the firm's stock in a transaction dated Monday, November 17th. The shares were sold at an average price of...
MarketBeat·20h ago
News Placeholder
CG Oncology, Inc. $CGON Holdings Decreased by Los Angeles Capital Management LLC
Los Angeles Capital Management LLC cut its position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 59.3% during the 2nd quarter, according to its most recent disclosure with the...
MarketBeat·2d ago
News Placeholder
Company News for Nov 17, 2025
Companies in The News Are: SR,CGON,GLOB,NU
Zacks·3d ago
News Placeholder
CG Oncology (NASDAQ:CGON) Releases Earnings Results, Meets Expectations
CG Oncology (NASDAQ:CGON - Get Free Report) announced its earnings results on Friday. The company reported ($0.57) EPS for the quarter, meeting the consensus estimate of ($0.57). CG Oncology had a...
MarketBeat·4d ago
News Placeholder
CG Oncology (NASDAQ:CGON) Trading 6.3% Higher - What's Next?
CG Oncology (NASDAQ:CGON) Trading 6.3% Higher - Here's What Happened...
MarketBeat·5d ago
News Placeholder
Candriam S.C.A. Takes Position in CG Oncology, Inc. $CGON
Candriam S.C.A. bought a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission...
MarketBeat·5d ago
News Placeholder
CG Oncology, Inc. (CGON) Reports Q3 Loss, Tops Revenue Estimates
CG Oncology, Inc. (CGON) delivered earnings and revenue surprises of 0.00% and +412.62%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates
ProQR (PRQR) delivered earnings and revenue surprises of -20.00% and -60.57%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago

Latest CGON News

View

Advertisement|Remove ads.

Advertisement|Remove ads.